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ABSTRACT
BACKGROUND AND PURPOSE: Several new MR imaging techniques have shown promising results in patients with Parkinson disease;
however, the comparative diagnostic values of these measures at the individual level remain unclear. Our aim was to compare the
diagnostic value of MR imaging biomarkers of substantia nigra damage for distinguishing patients with Parkinson disease from healthy
volunteers.
MATERIALS AND METHODS: Thirty-six patients and 20 healthy volunteers were prospectively included. The MR imaging protocol at 3T
included 3D T2-weighted and T1-weighted neuromelanin-sensitive images, diffusion tensor images, and R2* mapping. T2* high-resolution
images were also acquired at 7T to evaluate the dorsal nigral hyperintensity sign. Quantitative analysis was performed using ROIs in the
substantia nigra drawn manually around the area of high signal intensity on neuromelanin-sensitive images and T2-weighted images. Visual
analysis of the substantia nigra neuromelanin-sensitive signal intensity and the dorsolateral nigral hyperintensity on T2* images was
performed.
RESULTS: There was a significant decrease in the neuromelanin-sensitive volume and signal intensity in patients with Parkinson disease.
There was also a significant decrease in fractional anisotropy and an increase in mean, axial, and radial diffusivity in the neuromelanin-
sensitive substantia nigra at 3T and a decrease in substantia nigra volume on T2* images. The combination of substantia nigra volume, signal
intensity, and fractional anisotropy in the neuromelanin-sensitive substantia nigra allowed excellent diagnostic accuracy (0.93). Visual
assessment of both substantia nigra dorsolateral hyperintensity and neuromelanin-sensitive images had good diagnostic accuracy (0.91 and
0.86, respectively).
CONCLUSIONS: The combination of neuromelanin signal and volume changes with fractional anisotropy measurements in the substantia nigra
showed excellent diagnostic accuracy. Moreover, the high diagnostic accuracy of visual assessment of substantia nigra changes using dorsolateral
hyperintensity analysis or neuromelanin-sensitive signal changes indicates that these techniques are promising for clinical practice.
ABBREVIATIONS: AD  axial diffusivity; DNH  dorsal nigral hyperintensity; FA  fractional anisotropy; ICC  intraclass correlation coefficient; HV  healthy
volunteer; MD  mean diffusivity; NM  neuromelanin; PD  Parkinson disease; RD  radial diffusivity; ROC  receiver operating characteristic; SN  substantia nigra;
UPDRS  Unified Parkinson’s Disease Rating Scale
In Parkinson disease (PD), several MR imaging biomarkers havebeen successfully used to detect neurodegenerative changes in the
substantia nigra (SN).1-3 By means of DTI, decreased fractional
anisotropy (FA)2,3 and modifications in axial (AD),4 radial (RD),2
or mean (MD) diffusivity5 have been reported in the SN with
some variability across studies.5 In addition, increased iron con-
tent in the SN of patients with PD has been shown by R2* relax-
ometry2,3 or susceptibility imaging.6
In PD, dopaminergic neuronal loss occurs in the SN pars com-
pacta,1 and methods for specifically analyzing this region are of
particular interest. Neuromelanin (NM), a by-product of dopa-
mine that accumulates in dopaminergic neurons, has high signal
intensity on T1-weighted spin-echo images due to its paramag-
netic properties,7,8 and several studies have shown reduced NM
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signal or volume in the SN in PD.9,10 Because NM accumulates in
the substantia nigra pars compacta, NM MR imaging is a prom-
ising technique in PD.11
Histologic studies in PD have shown that depletion of dopa-
minergic neurons is most pronounced in the caudal and lateral
regions of the substantia nigra pars compacta, called nigrosome-
1.12 Signal changes in this area have been shown in PD using
high-resolution T2*-weighted or susceptibility-weighted imaging
at both 7T13 and 3T.14 The normal aspect of this dorsolateral
region is a hyperintense, ovoid area within the hypointense SN.
However, this hyperintensity, referred to as dorsal nigral hyper-
intensity (DNH), is lost in PD.13,14 Both NM-sensitive and DNH
imaging may be useful in clinical practice.13-15
Although these MR imaging techniques have shown good
results for differentiating patients from controls either sepa-
rately16,17 or by using a combination of diffusion and iron
imaging,3 the comparative diagnostic values of these measures
at the individual level remain unclear and have not been tested
yet. The aims of our study were to compare the diagnostic
efficacy of DTI, R2*, NM-sensitive imaging, and DNH and to
determine the best combination of measures to detect specific
SN alterations in PD.
MATERIALS AND METHODS
Subjects
Thirty-six patients were prospectively recruited from the Movement
Disorders Clinic at Pitié-Salpêtrière Hospital between April 2010 and
September 2012. The inclusion criteria were clinical diagnosis of id-
iopathic PD (according to UK Parkinson’s Disease Brain Bank crite-
ria), no or minimal cognitive disturbances (Mini-Mental State Ex-
amination score  24), age younger than 75 years, and complete
MR imaging examination on both 3T and 7T scanners. Patients were
compared with 20 healthy volunteers (HVs) with no medical history
of any neurologic disorders, having normal clinical examination
findings, and matched for age and sex. All subjects gave written in-
formed consent, and the local ethics committee approved the study
(CPP Paris VI, RCB: 2009-A00922–55).
Clinical and Neurologic Examination
Motor disability was evaluated using the Unified Parkinson’s Disease
Rating Scale, Part III (UPDRS-III) in the “ON” (peak effect of dopa-
minergic treatment) and “OFF” (12-hour dopaminergic treatment
withdrawal) conditions and the Hoehn and Yahr staging.
MR Imaging Acquisition
Acquisitions were performed using 3T Trio and 7T Magnetom
(Siemens, Erlangen, Germany) scanners and a 12-channel (3T)
or an 8-channel (7T) head coil for signal reception for all subjects.
The 3T protocol included high-resolution anatomic 3D T1WI,
T2WI, NM-sensitive spin-echo T1WI, DTI, and R2* mapping.
The 3D T1WI was acquired using a sagittal MPRAGE acquisition
(TI, 900 ms; TR/TE/flip angle, 2300 ms/4.18 ms/9°; 1 average;
voxel size, 1  1  1 mm3). NM-sensitive images were acquired
using 2D axial turbo spin-echo T1WI (TR/TE/flip angle, 900
ms/15 ms/180°; 3 averages; voxel size, 0.4  0.4  3 mm3). DTI
parameters were TR/TE/flip angle, 14,000 ms/101 ms/90°;
b-value,1500 s/mm2; voxel size, 1.7  1.7  1.7 mm3; 60 diffusion
gradient directions. R2* mapping was computed using a gradient
echo-planar imaging sequence with 6 TEs (range, 24 –94 ms); TR/
flip angle, 9000 ms/90°; voxel size, 2  2  2 mm3. The 7T image
acquisition included 3D T2*WI coronal images with TR/TE/flip
angle, 2180 ms/29.9 ms/65°; FOV, 192 mm2; voxel size, 0.5 
0.5  0.5 mm3; 40 slices.
Image Analysis
ROIs. SN segmentations at 3T were performed by 2 examiners
using FreeSurfer software (http://surfer.nmr.mgh.harvard.edu)
and at 7T by 1 trained examiner using ITK-SNAP 1.6 software
(www.itksnap.org).18 To evaluate the accuracy of segmentation at
7T, a second examiner performed segmentations in the last 10
selected subjects. The concordance between the segmentations
was good (Dice similarity coefficient  0.87).
For NM images, contours of the SN were manually drawn
around the area of high signal intensity twice by each blinded
rater. The concordance between the segmentations was good
(Dice similarity coefficient  0.8). This 3T NM ROI primarily
corresponded to the substantia nigra pars compacta.19 For 3T
T2WI and 7T T2*WI, the SN was defined as the area of hypoin-
tensity ventral to the red nucleus and dorsal to the cerebral pe-
duncle, primarily corresponding to the SN pars reticulata (Fig
1).19 The SN was separated from the subthalamic nucleus by a
small notch on its lateral and anterior borders. The subthalamic
nucleus was also segmented to avoid any error. All examiners were
blinded to the subject’s clinical status.
Quantitative Analysis. The volumes of NM-based ROIs were cal-
culated using in-house Matlab algorithms (MathWorks, Natick,
Massachusetts). The signal ratio was calculated by normalizing
the mean signal of the SN in each slice to the signal in the back-
ground region, which was manually traced, including the tegmen-
tum and superior cerebellar peduncles, as previously described.9
The interrater agreement was calculated, and the results were av-
eraged across the raters and segmentations. DTI and R2* mea-
sures in the SN were calculated using both 3T NM and 3T T2WI
ROIs. The DTI, NM-sensitive, and T2WI were coregistered to the
3D T1WI volume using the SPM coregister function (http://
www.fil.ion.ucl.ac.uk/spm/software/spm12). DTI preprocessing
was performed using the FMRIB Software Library, Version 5.0
(FSL; http://www.fmrib.ox.ac.uk/fsl). Motion and eddy currents
were corrected using the eddy_correct function in FSL. Echo-
planar deformations were corrected using field maps. FA and dif-
fusivity maps were computed with the DTIFit (http://fsl.fmrib.
ox.ac.uk/fsl/fsl-4.1.9/fdt/fdt_dtifit.html) function for the entire
volume. Noise filtering was applied. The mean value of each mea-
sure was computed in the SN ROIs. For R2* calculation, all images
were realigned, normalized, and coregistered. R2* maps were cal-
culated by fitting the data to the logarithmic signal decay over all
6 TEs. The mean R2* value was calculated over each ROI.
Blind Visual Analysis. Two raters visually analyzed the SN signal
intensity in the NM-sensitive images and the presence of DNH.
To assess intra- and interobserver reproducibility, each reading
was performed twice at a 4-week interval. There was no time limit
for visual evaluations. For conflicting cases, agreement between
raters was reached.
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NM-sensitive images were classified according to a 2-point
scale, as follows: 1, a normal aspect of the SN with high signal
intensity bilaterally and no volume loss, indicating a healthy sub-
ject; or 2, an abnormal aspect with reduced signal or volume of the
SN unilaterally or bilaterally, indicating a subject with pathology.
The DNH sign was categorized using a 2-point scale: 1, nor-
mal; or 2, pathologic. We used 2 classification methods: 1) Uni-
lateral or bilateral absence of DNH was considered pathologic,20
and 2) only bilateral DNH absence was considered pathologic.14
Statistical Analysis
Statistical analysis was performed using Matlab (MathWorks).
Intra- and interrater intraclass correlations (ICCs) were calcu-
lated for quantitative data. Group differences were determined
using a 1-way MANOVA. Preliminary assumptions of homoge-
neity of variance were assessed by the Levene test. Between-group
differences were estimated using Pillai’s Trace (http://www.statis
ticshowto.com/pillais-trace/). Follow-up univariate ANOVA was
performed for measures; differences were considered significant
at P  .05. The diagnostic threshold value was calculated using
receiver operating characteristic (ROC) curve analysis, and the sen-
sitivity and specificity of cutoff points were
estimated using the Youden index. The in-
ter- and intrarater agreement for qualita-
tive measurements was estimated using
the Cohen  coefficient. The sensitivity,
specificity, positive predictive value, and
negative predictive value were calculated.
Diagnostic accuracy between 0.9 and 1
was considered “excellent”; between 0.80
and 0.90, “good”; and between 0.70 and
0.80, “fair.” The best combination of vari-
ables for disease prediction was deter-
mined using a logistic regression model.
Associations between clinical measures
and MR imaging measurements were
studied regarding PD. Age and sex were
controlled by partial correlations followed
by a multiple comparisons permutation
approach. An approximate multivariate
permutation test was conducted, and the
sampling distribution was built to calcu-
late the corrected P value as the proportion




Thirty-six patients with PD (mean age,
60.1  10.1 years; 27 men) and 20 HVs
(mean age, 60.8  8.3 years; 12 men, P 
.2) were analyzed. The mean duration of
disease was 9.1  3.6 years, the mean
UPDRS-III-ON was 14.8  8.8, the
mean UPDRS-III-OFF was 28.3  9.6,
and the mean Hoehn and Yahr scale
score was 1.9  0.6. The mean UPDRS-
OFF score for the HV group was 0.8 
1.0. The mean Mini-Mental State Examination score was 27.9 
1.8 in PD and 28.8  1.1 in HV, P  .03. The mean Mattis score
was 137  5.2 in PD and 140  2.6 in HV, P  .009.
Quantitative MR Imaging Data Analysis
MANOVA preliminary assumptions revealed homogeneity of vari-
ance (Levene test). The between-group differences for all measures in
the SN were statistically significant [F(12,43)  5.387, P  .001; par-
tial 2  0.601, Pillai’s Trace].
The analysis was followed up by univariate ANOVAs for each
SN metric.
NM-Sensitive Volume. The average NM-sensitive volume was
lower in patients with PD than in HVs (F  24.85, P  .001, Table
1 and Fig 2A).
ROC analysis showed good discrimination between patients
with PD and HVs (Fig 3A and Table 2). Interrater (ICC  0.86;
95% CI, 0.78 – 0.91; P  .001) and intrarater (reader 1: ICC 
0.81; 95% CI, 0.65– 0.87; P  .001; reader 2: ICC  0.84; 95% CI,
0.75– 0.90; P  .001) agreements were good.
FIG 1. Segmentation of ROIs. Axial brain stem slices in a healthy volunteer (A) and a patient with
Parkinson disease (B) show reduction of the neuromelanin signal intensity in the substantia nigra
of the patient. Axial T2*WI 7T slices show dorsal nigral hyperintensity in a HV (C), which is absent
in the patient with PD (D). T2WI axial (E) and coronal (F) images of the SN in a HV show T2-based
segmentation of the SN.
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NM-Sensitive Signal. The average NM-sensitive signal in patients
with PD was lower than in that in HVs (F  27.39, P  .001; Table
1 and Fig 2B). ROC analysis showed good discrimination between
patients with PD and HVs (Fig 3A and Table 2). Interrater agree-
ment was excellent (ICC  0.91; 95% CI, 0.86 – 0.94; P  .001),
and intrarater agreement was good (reader 1: ICC  0.8; 95% CI,
0.69 – 0.87; reader 2: ICC  0.86; 95% CI, 0.77,0.91; P  .001).
DTI Parameters. For the DTI parameters, in the 3T NM SN ROI,
patients with PD showed an increased average MD (F  11.47,
P  .001), AD (F  11.23, P  .001), and RD (F  11.1, P  .002)
and a reduced FA (F  4.46, P  .04). In the 3D T2WI SN ROI,
an increase in RD (F  6.55, P  .01) and MD (F  5.23, P 
.03) was observed, with no significant differences in FA or AD
(Table 1 and Fig 2C). ROC analysis showed fair discrimination
between patients with PD and HVs for all parameters (Table 2
and Fig 3A).
R2*. There was no difference between patients with PD and HVs
for R2* in either 3T NM or 3T T2WI ROIs.
7T T2*WI SN Volume. Patients with PD exhibited lower 7T
T2*WI SN volumes than the HV group (F  4.06, P  .05) (Table
1 and Fig 2D). ROC analysis showed good discrimination between
patients with PD and HVs (Fig 3A and Table 2), with a higher area
under the curve for the NM-sensitive volume than for the 7T T2*
volume. Interrater agreement for volume measurements was ex-
cellent (ICC  0.9927; 95% CI, 0.9864 – 0.9961).
Best Variable Combinations. A logistic regression model was
used to determine the best variable combinations optimizing dis-
ease prediction. The logistic regression model was statistically sig-
nificant [2(77)  47.66, P  .001], explaining 78% (Nagelkerke
R2) of the variance and correctly classifying 93% of the cases.
Among predictor variables, 3 were statistically significant (signal,
volume, and FA in the 3T NM ROI), and the combination of these
variables improved sensitivity (91.7%), specificity (95%), and the
area under the curve (95.6; 95% CI, 0.903–1). While we consid-
ered only the combination of the signal and volume in the 3T NM
ROI, 89% of cases were correctly classified (area under the
curve  0.89; 95% CI, 0.8 – 0.98).
Qualitative Visual Analysis
NM-Sensitive Images. The 2 raters discriminated the patients
with PD and the HV group with good accuracy (Table 2). There
was strong intrarater agreement for rater 1 (Cohen   0.823;
95% CI, 0.674 – 0.972; P  .001) and rater 2 (  0.830; 95% CI,
0.688 – 0.971; P  .001). Good interrater agreement was also
found (  0.815; 95% CI, 0.632– 0.897; P  .001).
7T T2-weighted Images. The 2 raters discriminated between the
PD and HV subjects with good accuracy by both methods 1 and 2
(Table 2). There was good intrarater (  0.834; 95% CI, 0.806 –
0.862; P  .001) and interrater (  0.834; 95% CI, 0.806 – 0.862;
P  .001) agreement.
Correlation between MR Imaging Data and
Clinical Changes
For the 3T NM ROI, RD and MD in both hemispheres correlated
positively with the UPDRS-OFF score (RD: r  0.4, P  .007; MD:
r  0.4, P  .009), whereas FA correlated negatively with disease
duration for the 3T T2WI ROI (r  0.37, P  .015). Regarding




L 184.41  68.84 261.45  47.68b
R 176.91  62.89 258.89  46.62b
Mean LR 180.66  63.63 260.17  42.87b
Signal
L 106.74  2.64 110.21  2.55b
R 106.61  3.32 110.46  2.82b
Mean LR 110.56  2.62 110.33  2.40b
FA
L 0.32  0.04 0.34  0.04c
R 0.31  0.04 0.33  0.04
Mean LR 0.31  0.03 0.33  0.04c
AD
L 0.68  0.09 0.59  0.10d
R 0.70  0.08 0.62  0.10c
Mean LR 0.69  0.08 0.60  0.10c
RD
L 0.44  0.06 0.38  0.07d
R 0.46  0.06 0.40  0.07c
Mean LR 0.45  0.06 0.39  0.07c
MD
L 0.52  0.07 0.45  0.08d
R 0.54  0.06 0.48  0.08c
Mean LR 0.53  0.11 0.46  0.08c
R2*
L 35.91  4.95 36.66  2.84
R 36.10  6.64 36.54  2.80
Mean LR 35.65  6.46 36.60  2.64
3T T2 ROI
FA
L 0.39  0.06 0.42  0.06
R 0.37  0.06 0.40  0.05
Mean LR 0.38  0.06 0.40  0.05
AD
L 0.50  0.09 0.45  0.10
R 0.53  0.10 0.49  0.11
Mean LR 0.52  0.09 0.47  0.10
RD
L 0.30  0.06 0.26  0.10c
R 0.33  0.06 0.29  0.06c
Mean LR 0.32  0.06 0.28  0.0c
MD
L 0.37  0.07 0.32  0.07c
R 0.40  0.07 0.35  0.08c
Mean LR 0.38  0.07 0.34  0.08c
R2*
L 28.47  4.17 30.21  3.23
R 28.91  3.98 29.93  2.87
Mean LR 28.69  3.97 30.07  2.88
7T T2*WI ROI
T2WI volume
L 459.75  120.74 541.14  118.80c
R 468.11  130.00 523.01  121.85c
Mean LR 463.93  122.83 532.07  118.33c
Note:—L indicates left; R, right; LR, average of left and right.
a Quantitative measurements in the substantia nigra (mean and SD) are presented.
b Significant differences between patients with PD and HVs are indicated using
P  .001.
c Significant differences between patients with PD and HVs are indicated using
P  .05.
d Significant differences between patients with PD and HVs are indicated using
P  .005.
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the 7T T2*WI ROI, the SN volume bilaterally correlated positively
with disease duration (r  0.47, P  .018). No other significant
correlations were found for the quantitative data.
DISCUSSION
We found that NM imaging and DTI measures in the SN at 3T, as
well as the SN volume using T2* images at 7T, were significantly
different between patients with PD and HVs. The NM-based vol-
ume and signal had good diagnostic accuracy for separating pa-
tients with PD from HV subjects. DTI measures alone showed fair
diagnostic accuracy, and their combination with NM imaging
measures allowed excellent diagnostic performance. In addition,
visual measures (DNH rating and NM visual assessment) also
accurately distinguished patients with PD from the HV group.
The sensitivity was better with the DNH
rating, whereas the specificity was better
with NM visual assessment.
Histologic studies have shown that
neurodegeneration of the SN pars com-
pacta is associated with a reduced number
of pigmented neurons and a decrease in
NM in the remaining neurons.22,23 In line
with these findings, NM-sensitive MR im-
aging showed a decrease in both the size
and signal intensity of the SN area. These
observations are in agreement with previ-
ous studies and confirmed that NM imag-
ing is sensitive and specific for detecting
nigrostriatal damage in PD.9,10,17,24 The
combination of volume and signal loss
slightly increased the diagnostic accuracy.10
In our study, we found a significant
increase in diffusivity and a decrease in
FA in the 3T NM ROI in patients with
PD, which is congruent with previous
studies reporting FA reduction2-4 and
increases in RD2 and MD.5 These
changes may be explained by cell loss–
and microstructural damage–induced
changes in cell morphology and density
and the destruction of diffusion barri-
ers.24,25 In the 3T T2WI of the SN, we
observed only slight modifications in
FIG 2. Boxplot of the 3T NM SN volume (cubic millimeters) (A) and signal intensity ratio (B)
(calculated by normalizing the mean signal of the SN in each slice to the signal in the background
region), the 3T NM FA (C), and the 7T T2*WI SN volume (D) shows a reduction in all measures in
patients with PD compared with HVs.
FIG 3. Receiver operating characteristic curves of the 3T NM volume, the 3T NM signal intensity ratio, the 3T NM FA, the 7T T2* volume (A), and
the combination of the first 3 biomarkers for differentiating patients with PD from HVs (B).
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RD and MD. This finding is in line with a recent article that re-
ported PD-related DTI changes in the 3T NM ROI, correspond-
ing to the substantia nigra pars compacta, but not in the 3T T2WI
of the SN.19 The diagnostic accuracy of DTI for predicting PD
varies across studies, from very low to very high,4,26 and this was
improved using free water models or kurtosis.27,28 Some studies
have shown that a combination of FA and R2* improves discrim-
ination.2,3 Here, we show that the diagnostic accuracy of DTI
measures in the NM SN increased when combined with the NM
signal and volume changes, though this was not the case for the 3T
T2WI of the SN.
Quantitative measures are often challenging in clinical prac-
tice. First, DTI results largely differ among studies.2,3,19 Second,
SN volume on NM-sensitive images is variable across studies,
ranging from 128 to 370 mm3 in HVs and from 96 to 215 mm3 in
PD.7,10,15,17,24 These differences may be related to the scanner
type, magnetic field strength, sequence parameters, image-pro-
cessing methods, partial volume effect on 2D imaging, or ROI
selection methods.29 Within this context, qualitative measure-
ments such as visual assessment of NM-sensitive images or DNH
appear interesting.
Visual evaluation of NM signal changes was efficient for dis-
tinguishing patients from HVs, with a diagnostic accuracy com-
parable with that of quantitative measurements. Furthermore, vi-
sual analysis of SN signal changes was fast and did not require any
postprocessing algorithm. Therefore, visual reading of NM-sen-
sitive images might be of interest for the diagnosis of idiopathic
PD in clinical practice, as suggested previously.15
We found excellent diagnostic accuracy of DNH loss at 7T for
PD characterization, which is in agreement with previous studies
at 7T13,30 and 3T,14,31 supporting the use of this technique in a
clinical setting.32 Both approaches of visual analysis of DNH,
based on the uni- or bilateral presence of DNH loss, resulted in
equivalent overall correct classification.
Despite the good diagnostic accuracy of both DNH loss and
NM-sensitive visual assessment, further comparison of these 2
sequences in clinical practice is needed.
There was no significant increase in R2* in PD; such increases
have been observed in many, but not all,33 previous studies.2,3 A
possible explanation for the lack of R2* changes is that R2* may
decrease with disease progression.34 Although iron accumulation
leads to an increase in R2*, neuronal degeneration and gliosis
induce a decrease in R2 relaxation rates within the tissue.35
We found reduced T2*WI SN volume in PD at 7T, in line with
previous studies.36 Indeed, only 1 study at 7T reported an increase
in SN volume in patients with PD.30 These conflicting results may
be due to differences in sequence parameters or patient popula-
tions. Further analysis is needed to clarify this issue.
In the 3T NM ROI, the UPDRS score correlated with MD and
RD, and the disease duration correlated with FA and T2* volume.
Overall, correlations between DTI measures and clinical variables
are inconsistent across studies.2,3,19 Longitudinal studies and the
use of more complex diffusion models, such as free water diffu-
sion, may help enhance our understanding of this relationship.28
No correlation between the signal/volume loss and the UPDRS,
disease duration, or Hoehn and Yahr scale was observed, in line
with most previous studies.17 Nonetheless, 1 study did report a
correlation with the Hoehn and Yahr scale,24 and another, with
the UPDRS.9 There were no correlations between NM changes
and age or sex, consistent with some previous studies.9,24 The lack
of an age effect in our study may be explained by the relatively
small age range of the subjects.
This study has several limitations. First, visual assessment is
rater-dependent. However, both inter- and intrarater reproduc-
ibility were good. Manual segmentation is also dependent on the
rater’s reproducibility. However, Dice coefficients and the ICC
were high (0.8), suggesting good accuracy of measurements.
Second, the use of the 2D NM-sensitive sequences might have
biased the volume measurements because of partial volume ef-
fects. Regardless, the results for NM-based volumes in the current
study were comparable with those of previous studies.17 More-
over, ROC analysis allowed correct classification of the patients
with PD and the HV group. Third, quantification of the NM sig-
nal in the SN required normalization with the background signal.
Table 2: Diagnostic accuracy of quantitative and qualitative (visual) assessments
Sensitivity Specificity PPV NPV AUC (95% CI) Diagnostic Accuracy Cutoff
Quantitative measurements
3T NM signal 0.88 0.8 0.88 0.8 0.88 (0.79–0.97) 0.86 110.35
Volume 1 0.72 0.86 1 0.86 (0.76–0.95) 0.89 200.02
7T T2*WI volume 0.65 0.72 0.82 0.54 0.69 (0.53–0.84) 0.68 498.70
Diffusion measures
FA 3T NM 0.75 0.53 0.75 0.55 0.68 (0.54–0.82) 0.68 0.33
3T T2WI 0.65 0.70 0.8 0.52 0.64 (0.5–0.79) 0.66 0.37
AD 3T NM 0.7 0.65 0.78 0.54 0.73 (0.59–0.87) 0.68 0.64
3T T2WI 0.61 0.75 0.81 0.52 0.65 (0.49–0.80) 0.66 0.5
RD 3T NM 0.64 0.75 0.82 0.54 0.72 (0.58–0.86) 0.67 0.43
3T T2WI 0.72 0.6 0.76 0.55 0.68 (0.52–0.83) 0.67 0.29
MD 3T NM 0.67 0.75 0.83 0.56 0.72 (0.58–0.87) 0.7 0.51
3T T2WI 0.64 0.75 0.82 0.54 0.67 (0.53–0.82) 0.67 0.38
Combined measurements
NM signal and volume  FA (3T NM) 0.92 0.95 0.97 0.86 0.96 (0.9–1) 0.93 4.4
Qualitative evaluation
NM at 3T 0.83 0.9 0.94 0.9 – 0.86 –
DNH at 7T
Method 1 0.97 0.8 0.9 0.94 – 0.91 –
Method 2 0.94 0.85 0.92 0.9 – 0.91 –
Note:—AUC indicates area under the curve; NPV, negative predictive value; PPV, positive predictive value.
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To avoid the influence of potential inhomogeneity, the back-
ground ROI was large and based on several regions in each slice.
Fourth, the mean disease duration in our sample was long. Ac-
cordingly, markers for PD neurodegeneration need to be tested in
the early stages of PD. Finally, the DNH evaluation was performed
at 7T, which is not used in clinical practice, though previous stud-
ies have shown that 7T results are similar to those of 3T.31
CONCLUSIONS
The combination of signal, volume, and FA measurements on
NM-sensitive images allowed excellent diagnostic accuracy.
Moreover, excellent accuracy of the visual assessment of DNH
loss and NM-based signal changes in the SN confirmed that these
techniques are promising for clinical practice. A follow-up study
of signal intensity changes in the SN with disease progression will
help determine whether this marker could be used to track the
neurodegenerative process in neuroprotective trials.
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